Literature DB >> 32222571

Revenge lawsuit is a puzzle piece of the global crisis of Italian healthcare system.

Francesco Pata1, Francesco Ursini2, Gaetano Gallo3.   

Abstract

Entities:  

Year:  2020        PMID: 32222571      PMCID: PMC7138192          DOI: 10.1016/j.ijsu.2020.03.038

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


× No keyword cloud information.
Dear Editor, We read with interest the letter by Maria Michela Chiarello and colleagues [1] on “revenge lawsuit” as a subtle attempt by corrupted and anachronistic groups to neutralize proactive doctors who are aiming to improve the local healthcare system in Italy, especially in low-income areas. Furthermore, the concept of “second victim” aiming to support healthcare workers involved in adverse events, lawsuit or errors [2] is systematically ignored and this increases further the sense of frustration and isolation of the people involved. The reduction in accountability and effectiveness of public hospitals may benefit public-funded private clinics, directly or indirectly linked to economic and political lobbying, to induce promising healthcare workers to leave their jobs. Actually, we believe this represents only a fraction of the deep crisis of the Italian National Health System (“Sistema Sanitario Nazionale”, SSN), which is currently facing a serious gap in healthcare workers. As Luca La Colla healthcare recently highlighted in the Lancet [3], this gap is mainly due to a structural crisis of the SSN, rather than just a lack of planning of training posts over the last 10 years as previously suggested by Marta Paterlini [4]. Inadequate working conditions and salaries, the commixture of politics and healthcare system, obstacles in career progression and lack of meritocracy would represent an “untold truth”, making the system not attractive to new specialists and foreign doctors [5]. The current scenario of COVID-19 pandemic [6] represents a further challenge to a fragile system which is still waiting for global reform. However, some aspects of this systemic crisis might have been overlooked. First, the requirement of a specialty title to apply for a job position is largely compromised by the current laws. Indeed, according to the Italian legal system, there are no rigid distinctions among medical specialties. The ministerial decree n°30 approved in 1998 (https://www.gazzettaufficiale.it/eli/id/1998/02/14/098A0940/sg) established “equivalences” and “affinities” among different medical specialties, thus granting the possibility to apply for posts belonging to specialities that are different from the one owned by the applicant. For example, emergency medicine shows affinity with cardiology, gastroenterology, gerontology, pneumology, and internal medicine: this allows a specialist in emergency medicine to work in different environments, inducing a resource shift and jeopardising any attempt of long-term planning (https://www.quotidianosanita.it/lettere-al-direttore/articolo.php?articolo_id=66931). In addition, the potential harms of shifting to a specialty without undergoing a tailored training needs to be considered. Second, the application process for job positions in SSN is managed on a local basis, as different from other countries (e.g. in UK with NHS jobs, https://www.jobs.nhs.uk/). The procedure of providing documents varies considerably among applications, and all documents need to be sent in for each application, thus increasing costs, time, and potentially exposing the applicant to factual errors that might result in exclusion from competition. Furthermore, the selection process involves a three-step procedure which often requires weeks or months to complete. Third, revalidation which is affordable to all specialists is still not in place, and the scores need to assign a job are based on crude titles or years of practice in the public system, regardless of the actual performance and skills. A far-reaching reform of the health system is largely awaited in Italy. To leave the deep roots of these issues unresolved will eventually harm the system rather than to cure it.

Funding

None.

Ethical approval

Not applicable.

Research registration Unique Identifying Number (UIN)

Not applicable.

Provenance and peer review

Commentary, internally reviewed.

Guarantor

Francesco Pata.

Author contribution

Francesco Pata: Concept and design, acquisition of data, drafting the manuscript. Francesco Ursini: Concept and design, analysis and interpretation of data, critical revision. Gaetano Gallo: Concept and design, analysis and interpretation of data, writing, critical revision. All authors read and approved the final version of the manuscript.

Declaration of competing interest

None.
  6 in total

1.  Health worker gap in Italy: the untold truth.

Authors:  Luca La Colla
Journal:  Lancet       Date:  2019-08-17       Impact factor: 79.321

2.  Italy calls on retired doctors to fill health worker gap.

Authors:  Marta Paterlini
Journal:  Lancet       Date:  2019-04-13       Impact factor: 79.321

3.  Health-care inequalities in Italy: challenges for the Government.

Authors:  Prisco Piscitelli; Alessandro Miani; Alfredo Mazza; Maria Triassi; Antonella De Donno; Antonio Scala; Manuela Pulimeno; Alessandro Distante; Fabio Pollice; Annamaria Colao
Journal:  Lancet Public Health       Date:  2019-12

4.  Deaths, errors and second victims in surgery: an underestimated problem.

Authors:  G Pellino; I M Pellino
Journal:  Br J Surg       Date:  2020-01       Impact factor: 6.939

5.  A new item in Italian law: Revenge malpractice. A commentary on legal & ethical dilemmas in incidental findings during surgery - Review article.

Authors:  Maria Michela Chiarello; Giuseppe Brisinda
Journal:  Int J Surg       Date:  2020-02-24       Impact factor: 6.071

6.  Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.

Authors:  Rossella Porcheddu; Caterina Serra; David Kelvin; Nikki Kelvin; Salvatore Rubino
Journal:  J Infect Dev Ctries       Date:  2020-02-29       Impact factor: 0.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.